HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.

[1]  S. Fang,et al.  Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy , 2017, Autophagy.

[2]  Jun Yu,et al.  The ISG15-specific protease USP18 regulates stability of PTEN , 2016, Oncotarget.

[3]  X. Lei,et al.  JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling , 2016, Oncotarget.

[4]  Hui You,et al.  HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice. , 2016, Molecular endocrinology.

[5]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[6]  M. Malumbres,et al.  Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner , 2016, Cell Discovery.

[7]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[8]  Beixue Gao,et al.  Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation , 2014, The Journal of experimental medicine.

[9]  J. Coulson,et al.  The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells , 2013, Oncogene.

[10]  P. Lehner,et al.  MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation , 2013, Proceedings of the National Academy of Sciences.

[11]  Jianxun Song,et al.  USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. , 2012, Molecular cell.

[12]  J. Bruix,et al.  Hepatocellular carcinoma , 2012, The Lancet.

[13]  J. Sarkaria,et al.  WWP2 is an E3 ubiquitin ligase for PTEN , 2011, Nature Cell Biology.

[14]  P. Pandolfi,et al.  PTEN level in tumor suppression: how much is too little? , 2011, Cancer research.

[15]  S. Friedman,et al.  E3 Ubiquitin Ligase Synoviolin Is Involved in Liver Fibrogenesis , 2010, PloS one.

[16]  Pier Paolo Pandolfi,et al.  Subtle variations in Pten dose determine cancer susceptibility , 2010, Nature Genetics.

[17]  S. Ye,et al.  The HECT-Type E3 Ubiquitin Ligase AIP2 Inhibits Activation-Induced T-Cell Death by Catalyzing EGR2 Ubiquitination , 2009, Molecular and Cellular Biology.

[18]  Xinjiang Wang,et al.  Post-translational regulation of PTEN , 2008, Oncogene.

[19]  V. Stambolic,et al.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization , 2008, Proceedings of the National Academy of Sciences.

[20]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[21]  Donna D. Zhang,et al.  Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen‐induced arthritis , 2008, EMBO reports.

[22]  S. Yamasaki,et al.  The Roles of Synoviolin in Crosstalk Between Endoplasmic Reticulum Stress-Induced Apoptosis and p53 Pathway , 2007, Cell cycle.

[23]  Yingming Zhao,et al.  Wwp2-Mediated Ubiquitination of the RNA Polymerase II Large Subunit in Mouse Embryonic Pluripotent Stem Cells , 2007, Molecular and Cellular Biology.

[24]  Q. Zeng,et al.  PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. , 2007, Cancer research.

[25]  Cornelis J. Weijer,et al.  PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration , 2007, Current Biology.

[26]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[27]  S. Yamasaki,et al.  Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’ , 2007, The EMBO journal.

[28]  Sakae Tanaka,et al.  Essential Role of Synoviolin in Embryogenesis* , 2005, Journal of Biological Chemistry.

[29]  Ying Jin,et al.  Wwp2, an E3 Ubiquitin Ligase That Targets Transcription Factor Oct-4 for Ubiquitination* , 2004, Journal of Biological Chemistry.

[30]  V. Chau,et al.  Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[31]  M. Tai,et al.  Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma , 2003, Cancer.

[32]  J. D. McNeil,et al.  Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel. , 2002, American journal of physiology. Renal physiology.

[33]  M. Mansukhani,et al.  Reduced expression of PTEN correlates with breast cancer progression. , 2002, Human pathology.

[34]  Chien-Jen Chen,et al.  PTEN/MMAC1 mutations in hepatocellular carcinomas , 1999, Oncogene.

[35]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[36]  Carlos Cordon-Cardo,et al.  Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.

[37]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[38]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[39]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[40]  Y. Nomura,et al.  Novel functions of ubiquitin ligase HRD1 with transmembrane and proline-rich domains. , 2008, Journal of pharmacological sciences.